• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Cathepsin-sensing optical probe detects breast cancer lesions in mouse study

Article

CONTEXT: Proteases play a key role in cancer progression because of their involvement in the degradation of the extracellular matrix and basement membranes. In breast cancer, increased expression of cathepsin-B and other thiol proteases has been associated with increased aggressiveness and poor outcomes. Protease-sensing optical probes have been used in a variety of oncologic imaging applications. Dr. Christoph Bremer and colleagues at Massachusetts General Hospital and the University of Muenster in Germany examined the ability of a cathepsin-sensing fluorescent imaging probe to detect spontaneous breast cancer lesions.

RESULTS: Transgenic mice that spontaneously develop breast cancer were injected with a cathepsin-sensing imaging probe. Fluorescence reflectance imaging (FRI) and fluorescence-mediated tomography (FMT) were performed 24 hours after injection. MR images were obtained for anatomic coregistration with FMT. Both FRI and FMT imaging clearly delineated tumor nodules. Immunohistochemistry confirmed cathepsin-B expression by primary tumors.

IMAGE: FMT images were acquired at different levels in the tumor region, as illustrated in the corresponding sagittal MR images (left). After injection of the optical probe, strong tissue fluorescence could be reconstructed in the tumor region (right).

IMPLICATIONS: Because the expression of various proteases correlates with patient outcome, FRI and FMT with protease-sensing optical probes may offer a means of breast cancer detection. The imaging techniques may also be useful in noninvasive differentiation of breast tumors and may have application in the monitoring of treatment with protease inhibitors.

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.